As of 2024-12-15, the Intrinsic Value of GeneTether Therapeutics Inc (GTTX.CN) is
-0.14 CAD. This GTTX.CN valuation is based on the model Peter Lynch Fair Value.
With the current market price of 0.05 CAD, the upside of GeneTether Therapeutics Inc is
-409.53%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
-0.14 CAD
Intrinsic Value
GTTX.CN Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| Fair Value |
-0.14 - -0.14 |
-0.14 |
-409.53% |
| P/E |
0.04 - 0.04 |
0.04 |
-0.9% |
| DDM - Stable |
(0.03) - (0.04) |
(0.04) |
-178.7% |
| DDM - Multi |
(0.02) - (0.02) |
(0.02) |
-139.2% |
GTTX.CN Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
1.37 |
| Beta |
9.78 |
| Outstanding shares (mil) |
30.45 |
| Enterprise Value (mil) |
-0.41 |
| Market risk premium |
5.10% |
| Cost of Equity |
68.61% |
| Cost of Debt |
5.00% |
| WACC |
36.15% |